News & Events

Diazyme Laboratories, Inc. Announces Partnership for COVID-19 Molecular Diagnostics Test

30th Jul 2020

SAN DIEGO, CA (July 30, 2020) Diazyme announces partnership with Maccura Biotechnology (USA) LLC, launching a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. "Here at Diazyme, we continue to address gaps in testing during the COVID-19 public health emergency. The SARS-CoV-2 Fluorescent PCR Kit- Maccura Biotechnology (USA) LLC is a RT-PCR test intended for the qualitative detection of SARS- …
read more

Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test

8th Jul 2020

SAN DIEGO, CA  (July 8, 2020) Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer. "Diazyme has been at the forefront of the development effort to bring timely, high quality COVID-19 serology (antibody) tests during the publi …
read more

Diazyme Announces Continued Availability of COVID-19 Laboratory Run Antibody Tests

22nd May 2020

SAN DIEGO, CA – May 22, 2020 – Diazyme is making a statement to clear any confusion due to FDA’s May 21 press release regarding delisted tests from the FDA FAQ website. Diazyme had two types of tests under Section IV.D notification of FDA’s policy on the public health emergency for COVID-19. The Diazyme high-throughput laboratory run CLIA antibody test is NOT subject of delisting. Diazyme decid …
read more

Diazyme Laboratories, Inc. Announces Availability of COVID-19 Antibody Tests

23rd Mar 2020

SAN DIEGO, CA – (March 23, 2020) Diazyme announces the availability of two serological tests for the novel coronavirus (SARS-CoV-2), namely the Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits. The Diazyme IgG and IgM tests are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer. The Diazyme serological test notification is now listed on FDA’s EUA webs …
read more

Highlighted Study: Verification of FDA-Cleared Kappa and Lambda Free Light Chain Assays on the Beckman Coulter DxC 800

14th Nov 2019

SAN DIEGO, CA – (November 14, 2019) In a newly published study, Diazyme’s Kappa and Lambda Free Light Chain Assay performance was verified on the Beckman Coulter DxC 800. “We conclude the Diazyme κ and λ FLC assays when run on the Beckman-Coulter DxC analyzer exhibit excellent precision and accuracy, and are comparable to the Freelite assays on the Roche Cobas Integra analyzer”. Click below to …
read more